GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Phibro Animal Health PAHC · USD

Health Care · US listing · 🇺🇸 United States

Compare

34.61

+5.01%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2026

Revenue

$1.52bn

FY2017FY2026

Net income

$99.7m

FY2017FY2026

Free cash flow

$9.9m

FY2017FY2026

Shareholders' equity

$385.5m

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue$1.52bn$1.30bn$1.02bn$977.9m$942.3m$833.4m$800.4m$828.0m$820.0m$764.3m
Gross profit$512.5m$399.9m$313.1m$298.2m$285.4m$271.4m$256.9m$264.6m$266.9m$248.3m
Research and development—$23.7m$29.2m$24.4m$20.8m$17.8m$13.7m$12.1m$10.0m$9.4m
Operating income$194.4m$101.2m$53.3m$71.8m$79.0m$74.9m$69.2m$73.3m$98.9m$97.9m
Net income$99.7m$48.3m$2.4m$32.6m$49.2m$54.4m$33.6m$54.7m$64.9m$64.6m
Diluted earnings per share2.431.180.060.811.211.340.831.351.601.60

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets$1.50bn$1.36bn$982.2m$971.4m$931.7m$841.3m$784.1m$726.7m$671.7m$623.4m
Cash and short-term investments$82.0m$77.0m$114.6m$81.3m$91.2m$93.2m$91.3m$81.6m$79.2m$56.1m
Total liabilities$1.12bn$1.08bn$725.5m$688.9m$669.3m$602.8m$595.9m$510.7m$486.7m$472.2m
Debt$707.8m$718.7m$488.1m$474.8m$432.9m$392.1m$387.0m$326.2m$312.4m$313.1m
Shareholders' equity$385.5m$285.7m$256.6m$282.5m$262.4m$238.5m$188.2m$216.0m$185.0m$151.2m
Shares outstanding41m41m41m41m41m41m41m41m41m40m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations$69.0m$80.1m$87.6m$13.3m$31.6m$48.3m$59.3m$47.2m$70.0m$98.4m
Capital spending−$59.1m−$38.3m−$41.2m−$51.8m−$37.0m−$29.3m−$34.0m−$29.9m−$18.5m−$20.9m
Free cash flow$9.9m$41.8m$46.4m−$38.5m−$5.4m$19.0m$25.3m$17.3m$51.5m$77.5m
Dividends paid−$19.5m−$19.4m−$19.4m−$19.4m−$19.4m−$19.4m−$19.4m−$18.6m−$16.1m−$15.8m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue$396.7m$383.5m$373.9m$363.9m$378.7m$347.8m$309.3m$260.4m
Gross profit$141.4m$124.9m$132.7m$119.8m$110.0m$104.6m$101.9m$83.5m
Operating income$44.1m$48.0m$54.4m$47.9m$33.7m$33.5m$14.0m$17.8m
Net income$21.7m$24.0m$27.5m$26.5m$17.2m$20.9m$3.2m$7.0m
Diluted earnings per share0.530.590.670.650.420.510.080.17
Cash from operations—$16.0m$19.0m$9.0m$21.0m$43.0m$3.0m$12.0m
Capital spending—−$15.0m−$11.0m−$13.0m−$13.0m−$7.0m−$7.0m−$9.0m
Free cash flow—$1.0m$8.0m−$4.0m$8.0m$36.0m−$4.0m$3.0m
Total assets$1.50bn$1.45bn$1.41bn$1.39bn$1.36bn$1.32bn$1.29bn$966.3m
Cash and short-term investments$82.0m$77.5m$74.5m$85.3m$77.0m$70.4m$67.1m$89.8m
Debt—$744.9m$740.2m$752.0m$727.8m$736.4m$761.1m$482.1m
Shareholders' equity$385.5m$361.8m$332.4m$311.7m$285.7m$266.0m$246.8m$258.5m

Financial ratios

Data as of 29 Oct 2026

FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin33.7%30.9%30.8%30.5%30.3%32.6%—
Operating margin12.2%7.8%3.2%7.4%9.0%9.4%—
Net margin6.6%3.7%0.2%3.3%5.2%6.5%—
Return on equity25.9%16.9%0.9%11.5%18.7%22.8%—
Return on assets6.6%3.5%0.2%3.4%5.3%6.5%—
Free cash flow yield8.2%7.6%8.4%4.2%4.5%5.1%—
Revenue growth17.1%27.4%4.1%3.8%13.1%4.1%—
Earnings growth106.6%1897.7%-92.6%-33.7%-9.6%62.1%—
Current ratio2.96x2.76x2.94x3.33x2.97x3.04x—
Debt to equity1.93x2.55x1.93x1.70x1.67x1.67x—
Equity ratio25.7%21.0%26.1%29.1%28.2%28.4%—
Interest coverage3.89x3.04x1.50x4.01x6.98x7.53x—
R&D as a share of sales—1.8%2.9%2.5%2.2%2.1%1.7%
Buybacks as a share of market value-0.1%-0.6%-0.5%0.0%0.0%0.0%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue15.8%12.7%7.3%
Operating income39.3%21.0%8.5%
Net income45.2%12.9%1.9%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin32.4%31.7%31.6%31.8%
Operating margin10.5%8.7%8.7%9.5%
Net margin5.3%3.8%4.4%5.6%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings16.231.7353.914.411.115.223.418.420.120.9
Price to sales1.11.20.80.50.61.01.01.21.61.8

Market value over time

30 Nov 2016 to 28 Oct 2026, in USD

$1.10bn$1.55bn

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return90%84%-9%-37%8%-23%-23%-9%20%1%

Dividends and splits

Per share, in the currency the company pays

Paid for 12 years. Last went ex-dividend on 25 Nov 2026.

FY2027FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Paid in the year0.240.480.480.480.480.480.480.48

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.